These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 832589)

  • 21. [Ventricle function in low-dose digitoxin in patients with chronic heart failure (stage II/III)].
    Staiger J; Späth J; Dickhuth HH; Keul J
    Z Kardiol; 1983 Aug; 72(8):448-55. PubMed ID: 6684850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proceedings: Clinical value of serum digoxin and digitoxin determination in renal insufficiency].
    Klauser-Reucker C; Ferrini B; Klauser H; Moccetti T
    Schweiz Med Wochenschr; 1975 Dec; 105(51):1784-6. PubMed ID: 1215979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.
    Ochs HR; Smith TW
    J Clin Invest; 1977 Dec; 60(6):1303-13. PubMed ID: 914999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effects of antituberculosis drugs on the pharmacokinetics of digitoxin (author's transl)].
    Peters U; Hausamen TU; Grosse-Brockhoff F
    Dtsch Med Wochenschr; 1974 Nov; 99(47):2381-6. PubMed ID: 4426257
    [No Abstract]   [Full Text] [Related]  

  • 25. Disposition of digitoxin in renal failure.
    Vöhringer HF; Rietbrock N; Spurny P; Kuhlmann J; Hampl H; Baethke R
    Clin Pharmacol Ther; 1976 Apr; 19(4):387-95. PubMed ID: 1269191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pharmacokinetics of cefotaxime and metabolites in uremic patients (author's transl)].
    Fillastre JP; Ings RM; Leroy A; Godin M; Humbert G
    Nephrologie; 1982; 3(1):12-8. PubMed ID: 6283411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of nitrendipine in patients with renal failure: comparison to normal subjects.
    Aronoff GR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S974-6. PubMed ID: 6085387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of propofol and its conjugates after continuous infusion in normal and in renal failure patients: a preliminary study.
    Nathan N; Debord J; Narcisse F; Dupuis JL; Lagarde M; Benevent D; Lachatre G; Feiss P
    Acta Anaesthesiol Belg; 1993; 44(3):77-85. PubMed ID: 8310787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of triamterene and its active metabolites in renal insufficiency (author's transl)].
    Grebian B; Geissler HE; Knauf H; Mutschler E; Schnippenkoetter I; Völger KD; Wais U
    Arzneimittelforschung; 1978; 28(8):1420-5. PubMed ID: 582410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Digitoxin blood picture and renal elimination in long-term therapy with aluminum-magnesium hydroxide gel].
    Kuhlmann J
    Dtsch Med Wochenschr; 1984 Jan; 109(2):59-61. PubMed ID: 6692764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics of digoxin in Nigerians.
    Iyun AO; Lukanbi FA
    Afr J Med Med Sci; 1988 Mar; 17(1):9-15. PubMed ID: 2834936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in erythromycin pharmacokinetics induced by renal failure.
    Kanfer A; Stamatakis G; Torlotin JC; Fredj G; Kenouch S; Méry JP
    Clin Nephrol; 1987 Mar; 27(3):147-50. PubMed ID: 3494560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digitoxin and its cardioactive metabolites.
    Storstein L
    Clin Pharmacol Ther; 1975 Mar; 17(3):313-20. PubMed ID: 1120397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of digoxin and digitoxin in patients undergoing hemodialysis.
    Finkelstein FO; Goffinet JA; Hendler ED; Lindenbaum J
    Am J Med; 1975 Apr; 58(4):525-31. PubMed ID: 1124790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and bioavailability of digitoxin by a specific assay.
    MacFarland RT; Marcus FI; Fenster PE; Graves PE; Perrier D
    Eur J Clin Pharmacol; 1984; 27(1):85-9. PubMed ID: 6489430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interindividual differences in the pharmacokinetics of digitoxin and digoxin during long-term treatment.
    Haustein KO
    Eur J Clin Pharmacol; 1981 Jan; 19(1):45-51. PubMed ID: 7461023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cefamandol: pharmacokinetics with normal and impaired renal function (author's transl)].
    Höffler D; Moecke D; Sassmann M
    Dtsch Med Wochenschr; 1978 Aug; 103(34):1334-8. PubMed ID: 679835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of digitoxin and the bis- and monodigitoxosides of digitoxigenin in renal insufficiency.
    Graves PE; Fenster PE; MacFarland RT; Marcus FI; Perrier D
    Clin Pharmacol Ther; 1984 Nov; 36(5):607-12. PubMed ID: 6488681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacokinetics of digitoxin.
    Perrier D; Mayersohn M; Marcus FI
    Clin Pharmacokinet; 1977; 2(4):292-311. PubMed ID: 902449
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on digitalis. II. The influence of impaired renal function on the renal excretion of digitoxin and its cardioactive metabolites.
    Storstein L
    Clin Pharmacol Ther; 1974 Jul; 16(1):25-34. PubMed ID: 4843236
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.